The Fund's investment objective is to provide long term capital growth by investing in continental Europe.
Name | % Net Assets |
---|---|
Anheuser-Busch InBev | 4.7% |
Fresenius Medical Care AG | 4.4% |
Neopost | 4.3% |
Ryanair Holdings | 4.2% |
Software AG | 4.2% |
Unilever N.V. CVA | 4.1% |
Safran | 4.1% |
L.M. Ericsson Telephone Co. B | 4.1% |
SEB S.A., | 4.0% |
Banco Bilbao Vizcaya Argentaria S.A. | 4.0% |
Key | % Net Assets |
---|---|
Anheuser-Busch InBev | 4.7% |
Fresenius Medical Care AG | 4.4% |
Neopost | 4.3% |
Ryanair Holdings | 4.2% |
Other | 82.4% |
Date | 10-Sep-2021 |
---|---|
NAV | 927.10p |
Currency | GBP |
Change | 3.80p |
% | 0.41% |
YTD change | 927.10p |
YTD % | n/a |
Fund Inception | 28/02/1986 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £1,000 |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research